Tae-Wook Chung Selected Research

N-benzylcantharidinamide

5/2014

A novel cantharidin analog N-benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae-Wook Chung Research Topics

Disease

40	Neoplasms (Cancer) 12/2020 - 07/2003
8	Neoplasm Metastasis (Metastasis) 08/2017 - 12/2002
8	Hepatocellular Carcinoma (Hepatoma) 09/2014 - 07/2002
6	Leukemia 06/2015 - 01/2004
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2004
5	Colonic Neoplasms (Colon Cancer) 01/2019 - 07/2006
5	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2012
4	Inflammation (Inflammations) 01/2019 - 04/2013
3	Hypoxia (Hypoxemia) 07/2019 - 12/2011
3	Atherosclerosis 01/2017 - 08/2012
3	Hepatitis B 07/2004 - 12/2002
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 07/2006
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2019 - 09/2019
2	Liver Neoplasms (Liver Cancer) 07/2019 - 09/2014
2	Endometriosis 12/2018 - 08/2017
2	Lewis Lung Carcinoma 01/2018 - 01/2016
2	Disease Progression 01/2018 - 06/2011
2	Liver Diseases (Liver Disease) 09/2014 - 05/2004
2	Melanoma (Melanoma, Malignant) 10/2013 - 08/2013
2	Pathologic Neovascularization 02/2013 - 03/2009
2	Arthritis (Polyarthritis) 11/2012 - 03/2009
2	Hepatitis 11/2012 - 05/2004
2	Carcinogenesis 07/2006 - 11/2004
2	Chronic Hepatitis (Chronic Active Hepatitis) 05/2004 - 07/2002
1	Dermatitis 04/2022
1	Wounds and Injuries (Trauma) 02/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 09/2019
1	Arteriosclerosis 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019

Drug/Important Bio-Agent (IBA)

7	EnzymesIBA 12/2020 - 07/2002
7	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 12/2020 - 12/2011
7	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 12/2002
7	Phosphotransferases (Kinase)IBA 10/2018 - 06/2011
6	Tyrosine (L-Tyrosine)FDA Link 09/2014 - 11/2009
6	G(M3) GangliosideIBA 08/2014 - 07/2006
5	Lactic Acid (Lactate)FDA LinkGeneric 12/2020 - 11/2009
5	Adenosine Triphosphate (ATP)IBA 08/2020 - 12/2011
5	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 05/2004
4	CytokinesIBA 04/2022 - 01/2014
4	Pyruvic Acid (Pyruvate)IBA 12/2020 - 12/2011
4	Therapeutic UsesIBA 09/2019 - 11/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2019 - 03/2009
4	Lactate Dehydrogenase 5IBA 07/2019 - 12/2011
3	Oxidoreductases (Dehydrogenase)IBA 12/2020 - 08/2014
3	Oxygen (Dioxygen)IBA 12/2020 - 11/2009
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2018 - 01/2013
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 01/2017
3	caffeic acid phenethyl esterIBA 08/2014 - 11/2004
3	Proteins (Proteins, Gene)FDA Link 07/2006 - 07/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2006 - 07/2003
2	ascochlorinIBA 07/2019 - 04/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 04/2016
2	NAD (NADH)IBA 07/2019 - 12/2011
2	NF-kappa B (NF-kB)IBA 01/2019 - 11/2004
2	phorbolIBA 01/2019 - 03/2005
2	GlycosphingolipidsIBA 09/2017 - 01/2013
2	Protein Glutamine gamma Glutamyltransferase 2IBA 09/2017 - 11/2004
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2017 - 02/2013
2	GangliosidesIBA 01/2017 - 04/2016
2	SialyltransferasesIBA 01/2017 - 06/2006
2	Apolipoproteins B (ApoB)IBA 01/2017 - 06/2004
2	AntigensIBA 09/2014 - 05/2004
2	Small Interfering RNA (siRNA)IBA 09/2014 - 05/2008
2	hepatitis B virus X proteinIBA 09/2014 - 07/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2014 - 07/2006
2	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 11/2009
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2014 - 02/2013
2	Advanced Glycation End ProductsIBA 12/2013 - 04/2013
2	haematoside synthetaseIBA 03/2005 - 01/2004
1	Interleukin-13IBA 04/2022
1	Immunoglobulin E (IgE)IBA 04/2022
1	Chemokine CCL5IBA 04/2022
1	Interleukin-4 (Interleukin 4)IBA 04/2022
1	ChemokinesIBA 04/2022
1	CollagenIBA 02/2021
1	hemistepsinIBA 12/2020
1	Caspase 3 (Caspase-3)IBA 12/2020
1	Conditioned Culture MediaIBA 09/2020
1	Glutamine (L-Glutamine)FDA Link 09/2020
1	Liposomes (Liposome)IBA 09/2020
1	Clodronic Acid (Clodronate)IBA 09/2020
1	ilimaquinoneIBA 08/2020
1	3'-sialyllactoseIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Sialic Acid Binding Ig-like Lectin 3IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	Retinaldehyde (Retinal)IBA 10/2019
1	6'-sialyllactoseIBA 09/2019
1	Dihydrotestosterone (Androstanolone)IBA 09/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	machilin AIBA 07/2019
1	Benzene (Benzole)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Toll-Like Receptor 4IBA 01/2019
1	esculentoside HIBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2018 - 12/2005
2	Traditional Medicine (Folk Remedies) 01/2017 - 08/2016
2	Oral Administration 01/2006 - 11/2004